Opioid Safety Archives

Pharmacy chains should pay $878 million for opioid epidemic role, Ohio counties say

CVS Health, Legal, Ohio, Opioid Epidemic, Opioid Litigation, Opioid Overdoses, Opioid Prescriptions, Opioid Safety, Opioids, Opioids, Overdoses, Prescriptions, Public Health Emergencies, Retail Pharmacies, Therapeutics, Wal-Mart Stores, Walgreens Boots Alliance

A lawyer for two Ohio counties said CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. should fund an $878 million plan to address the opioid crisis there, as a first-of-its-kind trial got underway to determine the pharmacy chains’ contribution.

Biohaven Presentation at AAN Showed Decreased Opioid Use in Migraine Patients Following Nurtec® ODT Therapy: A Real-World Administrative Claims Analysis

Acute Migraine, Episodic Migraine, Hydrocodone, Migraine, Migraine Headaches, Opioid Dependence, Opioid Prescriptions, Opioid Safety, Prescriptions, R&D, Real world evidence, Research & Development, Therapeutics

Longitudinal medical and prescription claims were used to assess opioid prescriptions and MME’s dispensed amongst migraine patients nine months prior to and nine months following Nurtec® ODT initiation. Among […]

White Paper: Safety Profile of the Analgesic Trezix™ Capsules, Containing the Mild Opioid Dihydrocodeine

Acute Pain, Fentanyl, Hydrocodone, Morphine, Opioid Overdoses, Opioid Safety, Prescriptions, White Papers

Privately held pharmaceutical company Wraser Pharmaceuticals announced the publication of a White Paper addressing opioid safety.